I'm LongbridgeAI, I can summarize articles.Roivant Sciences director Meghan FitzGerald sold 5,112 common shares on September 15, 2026. The transaction included sales of 4,712 shares at $39.68 and 400 shares at $40.45, totaling approximately $203,159. Following these sales, her directly held stake in the company decreased to 36,108 common shares.
- Director Meghan FitzGerald sold 5,112 Roivant Sciences common shares on Sep. 15, 2026. * Sales priced at USD 39.68 per share for 4,712 shares, USD 40.45 for 400 shares. * Directly held stake fell to 36,108 common shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001349297-26-000008), on September 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here